(Q37344607)

19 August 2017

1 reference

title

FGFR3-related dwarfism and cell signaling (English)

1 reference

19 August 2017

Daisuke Harada

1

1 reference

19 August 2017

Yoshitaka Yamanaka

2

1 reference

19 August 2017

Koso Ueda

3

1 reference

19 August 2017

Hiroyuki Tanaka

4

1 reference

19 August 2017

Yoshiki Seino

5

1 reference

19 August 2017

publication date

9 December 2008

1 reference

Journal of Bone and Mineral Metabolism

19 August 2017

published in

1 reference

19 August 2017

volume

27

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

9-15

1 reference

https://scigraph.springernature.com/pub.10.1007/s00774-008-0009-7

19 August 2017

exact match

0 references

cites work

Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0009-7

Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0009-7

Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0009-7

FGF receptor mutations: dimerization syndromes, cell growth suppression, and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0009-7

Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0009-7

Cognitive and motor skills in achondroplastic infants: Neurologic and respiratory correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0009-7

Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCgamma-activated STAT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0009-7

Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0009-7

PTH has the potential to rescue disturbed bone growth in achondroplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-008-0009-7

FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease

21 January 2018

1 reference

12 December 2020

The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans

1 reference

12 December 2020

Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia

1 reference

12 December 2020

The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum

1 reference

12 December 2020

Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3.

1 reference

12 December 2020

Effect of growth hormone therapy in children with achondroplasia: growth pattern, hypothalamic-pituitary function, and genotype.

1 reference

12 December 2020

Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux

1 reference

12 December 2020

Thanatophoric dysplasia of the straight-bone type (type 2)

1 reference

12 December 2020

Lethal neonatal chondrodysplasias in the West of Scotland 1970-1983 with a description of a thanatophoric, dysplasialike, autosomal recessive disorder, Glasgow variant

1 reference

12 December 2020

Growth hormone therapy in hypochondroplasia

1 reference

12 December 2020

Thanatophoric dwarfism

1 reference

12 December 2020

Stop codon FGFR3 mutations in thanatophoric dwarfism type 1.

1 reference

12 December 2020

Insulin-like Growth Factor-1 Rescues the Mutated FGF Receptor 3 (G380R) Expressing ATDC5 Cells From Apoptosis Through Phosphatidylinositol 3-Kinase and MAPK

1 reference

12 December 2020

Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia

1 reference

12 December 2020

PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation

1 reference

12 December 2020

1 reference

12 December 2020

A novel mutation in FGFR-3 disrupts a putative N-glycosylation site and results in hypochondroplasia

1 reference

12 December 2020

Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway

1 reference

12 December 2020

Growth hormone therapy in achondroplasia

1 reference

12 December 2020

The kinase activity of fibroblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling

1 reference

12 December 2020

Fibroblast growth factor receptor 3 is a negative regulator of bone growth

1 reference

12 December 2020

Genetic disorders of the skeleton: a developmental approach

1 reference

12 December 2020

International nosology and classification of constitutional disorders of bone (2001).

1 reference

12 December 2020

Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3

1 reference

12 December 2020

Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.

1 reference

12 December 2020

Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia--genetic short limbed dwarfism

1 reference

12 December 2020

Control of Bone Growth by Fibroblast Growth Factors

1 reference

12 December 2020

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions

1 reference

12 December 2020

Limb lengthening in short stature patients.

1 reference

12 December 2020

Cellular signaling by fibroblast growth factor receptors

1 reference

12 December 2020

Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I

1 reference

12 December 2020

Cell responses to FGFR3 signalling: growth, differentiation and apoptosis

1 reference

12 December 2020

Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia

1 reference

12 December 2020

A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia

1 reference

12 December 2020

Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B.

1 reference

12 December 2020

Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia.

1 reference

12 December 2020

Thanatophoric dysplasia: fetal manifestations and prenatal diagnosis

1 reference

12 December 2020

A morphometric analysis of the craniofacial configuration in achondroplasia.

1 reference

12 December 2020

Differential effects of fibroblast growth factor (FGF) 9 and FGF2 on proliferation, differentiation and terminal differentiation of chondrocytic cells in vitro

1 reference

12 December 2020

1 reference

12 December 2020

Efficacy of growth hormone therapy for patients with skeletal dysplasia.

1 reference

12 December 2020

Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations

1 reference

12 December 2020

Clinical and genetic heterogeneity of hypochondroplasia

1 reference

12 December 2020

Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3

1 reference

12 December 2020

A new neonatal short limbed dwarfism.

1 reference

12 December 2020

A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene

1 reference

12 December 2020

Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis

1 reference

12 December 2020

Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia

1 reference

12 December 2020

Lengthening of the lower limbs in patients with achondroplasia and hypochondroplasia.

1 reference

12 December 2020

Multivalent Ligand-Receptor Binding Interactions in the Fibroblast Growth Factor System Produce a Cooperative Growth Factor and Heparin Mechanism for Receptor Dimerization

1 reference

12 December 2020

Genotype and phenotype in hypochondroplasia

1 reference

12 December 2020

Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype

1 reference

12 December 2020

Thanatophoric dysplasia and cloverleaf skull

1 reference

12 December 2020

A novel missense mutation Ile538Val in the fibroblast growth factor receptor 3 in hypochondroplasia. Mutations in brief no. 122. Online

1 reference

12 December 2020

Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.

1 reference

12 December 2020

Molecular-pathogenetic classification of genetic disorders of the skeleton

1 reference

12 December 2020

Thanatophoric dysplasia: an autosomal dominant condition?

1 reference

12 December 2020

10.1007/S00774-008-0009-7

Identifiers

DOI

1 reference

19 August 2017

1 reference